Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s stock price traded up 37.5% during trading on Thursday . The stock traded as high as GBX 24 ($0.29) and last traded at GBX 22 ($0.27). 369,955 shares were traded during mid-day trading, an increase of 231% from the average session volume of 111,807 shares. The stock had previously closed at GBX 16 ($0.20).
Celadon Pharmaceuticals Stock Performance
The stock has a market cap of £28.36 million, a P/E ratio of -514.94 and a beta of -0.26. The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 194.82. The company’s 50-day simple moving average is GBX 17.86 and its 200 day simple moving average is GBX 33.91.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Read More
- Five stocks we like better than Celadon Pharmaceuticals
- Short Selling – The Pros and Cons
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Basic Materials Stocks Investing
- How Do Stock Buybacks Affect Shareholders?
- How to Choose Top Rated Stocks
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
